@article{f04d8bca6919455e870676e29908af6b,
title = "Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy",
author = "Stoner, {Ryan C.} and Press, {Richard D.} and Maxson, {Julia E.} and Tyner, {Jeffrey W.} and Dao, {Kim Hien T.}",
note = "Funding Information: Acknowledgements This work was supported in part by Incyte, Inc. KHD served on advisory board meetings and received compensation from Incyte. JWT received grants from the National Cancer Institute (1U01CA217862, 1U54CA224019, and 1R01CA183947), the V Foundation for Cancer Research, and the Gabrielle{\textquoteright}s Angel Foundation for Cancer Research. JWT has received research support from Agios, Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros, and Takeda; JWT is a cofounder of Vivid Biosciences.",
year = "2020",
month = jun,
day = "1",
doi = "10.1038/s41375-019-0688-1",
language = "English (US)",
volume = "34",
pages = "1684--1688",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "6",
}